Christopher Labos1, George Thanassoulis2. 1. Division of Cardiology, Preventive and Genomic Cardiology, McGill University Health Center, 1001 Boulevard Decarie, Montreal, QC, H4A 3J1, Canada. 2. Division of Cardiology, Preventive and Genomic Cardiology, McGill University Health Center, 1001 Boulevard Decarie, Montreal, QC, H4A 3J1, Canada. george.thanassoulis@mcgill.ca.
Abstract
PURPOSE OF REVIEW: This review aims to summarize the research on genetic risk scores and their ability to improve risk prediction in both a primary and a secondary prevention population. RECENT FINDINGS: Several groups have examined the role of genetic scores in different patient populations. Recent studies have capitalized on the growing number of identified genetic variants to construct polygenic risk scores that include hundreds and sometimes thousands of SNPs. Also, recent studies have demonstrated that individuals with high genetic risk scores can attenuate their risk with lifestyle modifications and with statins, for which the benefit of treatment may be greater in those at highest genetic risk. Genetic risk scores when added to existing clinical models appear to improve risk prediction, particularly in the setting of incident cardiovascular disease and may provide actionable information to optimize prevention early in life. Future research will need to establish how to best use this genetic risk information either as a means to further individualize treatment decisions or to better identify high-risk populations.
PURPOSE OF REVIEW: This review aims to summarize the research on genetic risk scores and their ability to improve risk prediction in both a primary and a secondary prevention population. RECENT FINDINGS: Several groups have examined the role of genetic scores in different patient populations. Recent studies have capitalized on the growing number of identified genetic variants to construct polygenic risk scores that include hundreds and sometimes thousands of SNPs. Also, recent studies have demonstrated that individuals with high genetic risk scores can attenuate their risk with lifestyle modifications and with statins, for which the benefit of treatment may be greater in those at highest genetic risk. Genetic risk scores when added to existing clinical models appear to improve risk prediction, particularly in the setting of incident cardiovascular disease and may provide actionable information to optimize prevention early in life. Future research will need to establish how to best use this genetic risk information either as a means to further individualize treatment decisions or to better identify high-risk populations.
Entities:
Keywords:
Genetic risk score; Prevention; Risk prediction; Single nucleotide polymorphism
Authors: Waseem Hindieh; Louise Pilote; Asim Cheema; Hatim Al-Lawati; Christopher Labos; Line Dufresne; James C Engert; George Thanassoulis Journal: Arterioscler Thromb Vasc Biol Date: 2016-04-21 Impact factor: 8.311
Authors: N T Krarup; A Borglykke; K H Allin; C H Sandholt; J M Justesen; E A Andersson; N Grarup; T Jørgensen; O Pedersen; T Hansen Journal: Atherosclerosis Date: 2015-03-16 Impact factor: 5.162
Authors: John G Canto; Catarina I Kiefe; William J Rogers; Eric D Peterson; Paul D Frederick; William J French; C Michael Gibson; Charles V Pollack; Joseph P Ornato; Robert J Zalenski; Jan Penney; Alan J Tiefenbrunn; Philip Greenland Journal: JAMA Date: 2011-11-16 Impact factor: 56.272
Authors: Diego Ardissino; Carlo Berzuini; Piera Angelica Merlini; Pier Mannuccio Mannucci; Aarti Surti; Noel Burtt; Benjamin Voight; Marco Tubaro; Flora Peyvandi; Marta Spreafico; Patrizia Celli; Daniela Lina; Maria Francesca Notarangelo; Maurizio Ferrario; Raffaela Fetiveau; Giorgio Casari; Michele Galli; Flavio Ribichini; Marco L Rossi; Francesco Bernardi; Nicola Marziliano; Pietro Zonzin; Francesco Mauri; Alberto Piazza; Luisa Foco; Luisa Bernardinelli; David Altshuler; Sekar Kathiresan Journal: J Am Coll Cardiol Date: 2011-07-19 Impact factor: 24.094
Authors: Cristen J Willer; Serena Sanna; Anne U Jackson; Angelo Scuteri; Lori L Bonnycastle; Robert Clarke; Simon C Heath; Nicholas J Timpson; Samer S Najjar; Heather M Stringham; James Strait; William L Duren; Andrea Maschio; Fabio Busonero; Antonella Mulas; Giuseppe Albai; Amy J Swift; Mario A Morken; Narisu Narisu; Derrick Bennett; Sarah Parish; Haiqing Shen; Pilar Galan; Pierre Meneton; Serge Hercberg; Diana Zelenika; Wei-Min Chen; Yun Li; Laura J Scott; Paul A Scheet; Jouko Sundvall; Richard M Watanabe; Ramaiah Nagaraja; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; George Davey-Smith; Alan R Shuldiner; Rory Collins; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Antonio Cao; Francis S Collins; Edward Lakatta; G Mark Lathrop; Michael Boehnke; David Schlessinger; Karen L Mohlke; Gonçalo R Abecasis Journal: Nat Genet Date: 2008-01-13 Impact factor: 38.330
Authors: Gad Abraham; Aki S Havulinna; Oneil G Bhalala; Sean G Byars; Alysha M De Livera; Laxman Yetukuri; Emmi Tikkanen; Markus Perola; Heribert Schunkert; Eric J Sijbrands; Aarno Palotie; Nilesh J Samani; Veikko Salomaa; Samuli Ripatti; Michael Inouye Journal: Eur Heart J Date: 2016-09-21 Impact factor: 29.983
Authors: Augusto Anguita-Ruiz; Juan Antonio Zarza-Rebollo; Ana M Pérez-Gutiérrez; Esther Molina; Blanca Gutiérrez; Juan Ángel Bellón; Patricia Moreno-Peral; Sonia Conejo-Cerón; Jose María Aiarzagüena; M Isabel Ballesta-Rodríguez; Anna Fernández; Carmen Fernández-Alonso; Carlos Martín-Pérez; Carmen Montón-Franco; Antonina Rodríguez-Bayón; Álvaro Torres-Martos; Elena López-Isac; Jorge Cervilla; Margarita Rivera Journal: Transl Psychiatry Date: 2022-01-24 Impact factor: 7.989
Authors: P L Thompson; J Hui; J Beilby; L J Palmer; G F Watts; M J West; A Kirby; S Marschner; R J Simes; D R Sullivan; H D White; R Stewart; A M Tonkin Journal: BMC Cardiovasc Disord Date: 2022-03-09 Impact factor: 2.298